2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Prevention of Sudden Death in Hypertrophic Cardiomyopathy

Boriani, G., Maron, B. J., Shen, W.-K., & Spirito, P. (2004) · Circulation · doi:10.1161/01.cir.0000144463.65977.c9 · Cited by 50

Information recall in genetic counselling: a pilot study of its assessment

Michie, S., French, D., Allanson, A., Bobrow, M., & Marteau, T. M. (1997) · Patient Education and Counseling · doi:10.1016/s0738-3991(97)00068-2 · Cited by 49

Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy

Kaźmierczak, J., Kornacewicz‐Jach, Z., Kisły, M., et al. (1998) · Heart · doi:10.1136/hrt.80.3.257 · Cited by 49

Acute Effect of Nonsurgical Septal Reduction Therapy on Regional Left Ventricular Asynchrony in Patients With Hypertrophic Obstructive Cardiomyopathy

Park, T.-H., Lakkis, N. M., Middleton, K. J., et al. (2002) · Circulation · doi:10.1161/01.cir.0000025418.96995.ed · Cited by 49

Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy

Maron, B. J., & Semsarian, C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq111 · Cited by 47

Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy

Reinhard, W., ten Cate, F. J., SCHOLTEN, M. F., Laat, L. E. D. G., & Vos, J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.065 · Cited by 47

Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective

Veselka, J., Zemánek, D., Tomašov, P., et al. (2009) · Heart and Vessels · doi:10.1007/s00380-008-1083-4 · Cited by 46

Sustained Ventricular Tachycardia Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Simón, R., Crawford, F. A., Spencer, W. H., et al. (2005) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2005.00278.x · Cited by 46

Antidepressant Treatment with Maprotiline* in the Management of Emotional Disturbances in Patients with Acute Myocardial Infarction: A Controlled Study

Selvini, A., Rossi, C. R., Belli, C., et al. (1976) · Journal of International Medical Research · doi:10.1177/030006057600400106 · Cited by 46

Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy–causing mutations in the β-myosin heavy chain, α-tropomyosin, and myosin-binding protein C genes

Poutanen, T., Tikanoja, T., Jääskeläinen, P., Jokinen, E. V., Silvast, A., Laakso, M., & Kuusisto, J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.12.005 · Cited by 45

Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy

Monakier, D., Woo, A., Puri, T., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.030 · Cited by 45

Usefulness of Clinical, Echocardiographic, and Procedural Characteristics to Predict Outcome After Percutaneous Transluminal Septal Myocardial Ablation

van der Lee, C., Schölzel, B. E., ten Berg, J. M., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.01.003 · Cited by 45

Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy

Kimball, B. P., Bui, S., & Wigle, E. D. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90760-7 · Cited by 45

Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy and Sudden Death

Nishimura, R. A., & Ommen, S. R. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.110.952085 · Cited by 44

Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest

Gadler, F., Linde, C. M., JUHLIN‐DANNFELT, A., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015309 · Cited by 43

Myocardial Mechanics Explains the Time Course of Benefit for Septal Ethanol Ablation for Hypertrophic Cardiomyopathy

Carasso, S., Woo, A., Yang, H., Schwartz, L., Vannan, M. A., Jamorski, M., Linghorne, M., Wigle, E. D., & Rakowski, H. (2007) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.08.020 · Cited by 43

Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.

Doi, Y., & Kitaoka, H. (2001) · PubMed · Cited by 43

Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.

Swanton, R. H., Brooksby, I. A. B., Jenkins, B. S., et al. (1977) · PubMed · Cited by 43

Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy

Hori, Y., Ueda, M., Nakayama, T., et al. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.182 · Cited by 42

Left Atrial Index Is a Predictor of Exercise Capacity in Patients with Hypertrophic Cardiomyopathy

Kjærgaard, J., Johnson, B. D., Pellikka, P. A., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.05.020 · Cited by 42

Abnormally Thickened Papillary Muscle Resulting in Dynamic Left Ventricular Outflow Tract Obstruction: An Unusual Presentation of Hypertrophic Cardiomyopathy

Austin, B. A., Kwon, D. H., Smedira, N. G., et al. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.10.022 · Cited by 41

Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients

Lakkis, N. M., Plana, J. C., Nagueh, S. F., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01748-9 · Cited by 41

Cardiomyopathy and heart transplantation in children

Towbin, J. A. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200205000-00011 · Cited by 41

From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy

Driest, S. L. V., Maron, B. J., & Ackerman, M. J. (2003) · Heart · doi:10.1136/heart.90.1.7 · Cited by 40

Catheter-based septalablation for symptomatic hypertrophic obstructive cardiomyopathy:

Faber, L., Seggewiß, H., Gietzen, F. H., et al. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-0256-8 · Cited by 38

Dual Chamber Pacing for Patients With Hypertrophic Obstructive Cardiomyopathy: A Clinical Perspective in 2000

Erwin, J. P., Nishimura, R. A., Lloyd, M. A., & Tajik, A. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.2.173 · Cited by 38

Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy

Sugihara, H., Taniguchi, Y., Ito, K., Terada, K., Matsumoto, K., Kinoshita, N., Azuma, A., Ushuima, Y., Maeda, T., & Nakagawa, M. (1998) · Annals of Nuclear Medicine · doi:10.1007/bf03164924 · Cited by 37

Complete pulmonary vein isolation guided by three-dimensional electroanatomical mapping for the treatment of paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy

Liu, X., OUYANG, F., Mavrakis, H. E., MA, C., DONG, J., Ernst, S., Bansch, D., Antz, M., & Kück, K. (2005) · EP Europace · doi:10.1016/j.eupc.2005.05.015 · Cited by 37

Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients

Hauser, R. G., Maron, B. J., Marine, J. E., Lampert, R. J., Kadish, A. H., Winters, S. L., Scher, D. L., Biria, M., & Kalia, A. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.08.021 · Cited by 36

Mitral valve replacement and septal myomectomy in hypertrophic cardiomyopathy. Ten-year follow-up in 80 patients.

Krajcer, Z., Leachman, R. D., Cooley, D. A., et al. (1988) · PubMed · Cited by 36

Sudden cardiac death in familial hypertrophic cardiomyopathy: are “benign” mutations really benign?

Semsarian, C., Yu, B., Ryce, C., Lawrence, C., Washington, H., & Trent, R. J. (1997) · Pathology · doi:10.1080/00313029700169155 · Cited by 35

Age-Related Hemodynamic and Morphologic Differences in Patients Undergoing Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Veselka, J., aacute, R. D., aacute, J. P. A. L. I. C., et al. (2006) · Circulation Journal · doi:10.1253/circj.70.880 · Cited by 35

Myocardial perfusion SPECT imaging in patients with myocardial bridging

Vallejo, E., Morales, M. T., Sánchez, I., et al. (2005) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2005.01.009 · Cited by 34

Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy

ElBardissi, A. W., Dearani, J. A., Nishimura, R. A., Ommen, S. R., Stulak, J. M., & Schaff, H. V. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61096-3 · Cited by 34

Medical and surgical treatment of the cardiomyopathies.

Ed, W., Ag, A., & Felderhof, C. H. (1974) · PubMed · Cited by 34

Hypertrophic Cardiomyopathy Centers

Maron, B. J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.05.064 · Cited by 33

Monomorphic Ventricular Tachycardia: A Late Complication of Percutaneous Alcohol Septal Ablation for Hypertrophic Cardiomyopathy

McGregor, J. B., Rahman, A. M., Rosanio, S., et al. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200409000-00011 · Cited by 33

Utility of Cardiovascular Magnetic Resonance in the Diagnosis of Anderson-Fabry Disease

Gange, C. A., Link, M. S., & Maron, M. S. (2009) · Circulation · doi:10.1161/circulationaha.109.849828 · Cited by 33

Surgical correction of hypertrophic obstructive cardiomyopathy with combined myectomy, mobilisation and partial excision of the papillary muscles

Schoendube, F. A., Klues, H. G., Reith, S., et al. (1994) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/1010-7940(94)90044-2 · Cited by 33

Dynamic Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy Revisited Significance, Pathogenesis, and Treatment

Sherrid, M. V. (1998) · Cardiology in Review · doi:10.1097/00045415-199805000-00009 · Cited by 32

Clinical Application of Cardiac CMR

Al-Mallah, M. H. (2009) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0463 · Cited by 32

Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy: Figure 1

Dimitrow, P. P., & Dubiel, J. S. (2004) · Heart · doi:10.1136/hrt.2003.030353 · Cited by 30

Myocardial bridging and hypertrophic cardiomyopathy: relief of ischemia by surgery

Pey, J., de Dios, R. M., & Epeldegui, A. (1985) · International Journal of Cardiology · doi:10.1016/0167-5273(85)90224-4 · Cited by 29

Depression, Anxiety, and Quality of Life in Patients With Obstructive Hypertrophic Cardiomyopathy Three Months After Alcohol Septal Ablation

Serber, E. R., Sears, S. F., Nielsen, C. D., Spencer, W. H., & Smith, K. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.063 · Cited by 29

Objectives of genetic counselling: differing views of purchasers, providers and users

Michie, S. G., Allanson, A., Armstrong, D., et al. (1998) · Journal of Public Health · doi:10.1093/oxfordjournals.pubmed.a024794 · Cited by 29

Incremental Value of Left Ventricular Diastolic Function Reserve Index for Predicting Exercise Capacity in Patients with Hypertrophic Cardiomyopathy

Choi, E., Ha, J., Rim, S., et al. (2007) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.08.041 · Cited by 28

Hypertrophic obstructive cardiomyopathy: Preoperative echocardiographic predictors of outcome after septal myectomy

McCully, R. B., Nishimura, R. A., Bailey, K. R., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00038-1 · Cited by 28

Editorial

Criley, J. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00590-6 · Cited by 28

Hypertrophic Cardiomyopathy Without Hypertrophy

Maron, B. J., & Ho, C. Y. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.09.008 · Cited by 27

Myths About Surgical Myectomy: Rumors of Its Death Have Been Greatly Exaggerated

Maron, B. J., Ommen, S. R., Nishimura, R. A., & Dearani, J. A. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.10.055 · Cited by 27

Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy

Criley, J. M., & Siegel, R. J. (1986) · Postgraduate Medical Journal · doi:10.1136/pgmj.62.728.515 · Cited by 25

Novel Hypertrophic Cardiomyopathy Phenotype: Segmental Hypertrophy Isolated to the Posterobasal Left Ventricular Free Wall

Maron, B. J., Sherrid, M. V., Haas, T. S., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.04.037 · Cited by 25

New Insights Into Effective CPR: Cardiocerebral Resuscitation for Primary Cardiac Arrest

Ewy, G. A. (2009) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0462 · Cited by 25

Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy

Pedone, C., Vijayakumar, M., Ligthart, J. M. R., et al. (2005) · International Journal of Cardiovascular Interventions · doi:10.1080/14628840500280575 · Cited by 24

Myocardial Perfusion Imaging in Hypertrophic Cardiomyopathy

Dilsizian, V., Panza, J. A., & Bonow, R. O. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.07.013 · Cited by 24

Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy

Sorajja, P., Nishimura, R. A., Ommen, S. R., Rihal, C. S., Gersh, B. J., & Holmes, D. R. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.07.004 · Cited by 23

New treatment methods for patients with hypertrophic obstructive cardiomyopathy

Lakkis, N. M. (2000) · Current Opinion in Cardiology · doi:10.1097/00001573-200005000-00009 · Cited by 23

Surgical intervention and support for cardiomyopathies of childhood

Williams, W. G., & Rebeyka, I. M. (1992) · Progress in Pediatric Cardiology · doi:10.1016/1058-9813(92)90033-i · Cited by 22

Cardiovascular Advisory Panel Guidelines for the Medical Examination of Commercial Motor Vehicle Drivers

Blumenthal, R. S., Braunstein, J. B., Connolly, H. M., Epstein, A. E., Gersh, B. J., & Wittels, E. H. (2002) · Cited by 21

Parental Knowledge and Attitudes Toward Hypertrophic Cardiomyopathy Genetic Testing

Fitzgerald‐Butt, S. M., Byrne, L., Gerhardt, C. A., Vannatta, K. A., Hoffman, T. M., & McBride, K. L. (2009) · Pediatric Cardiology · doi:10.1007/s00246-009-9583-2 · Cited by 21

Pilots, hypertrophic cardiomyopathy, and issues of aviation and public safety

Maron, B. J., Barry, J. A., & Poole, R. S. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.038 · Cited by 20

Rationale and Process: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006

Mehra, M. R., Jessup, M. L., Gronda, E., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.006 · Cited by 19

Clinical and Echocardiographic Variables Fail to Predict Response to Dual-Chamber Pacing for Hypertrophic Cardiomyopathy

Binder, J. S., Ommen, S. R., Sorajja, P., et al. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.11.014 · Cited by 18

Amiodarone dose titration: a method to minimise side effects during long term therapy.

McKenna, W., Harris, L., Jp, M., et al. (1986) · PubMed · Cited by 16

Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans

Bergfeldt, L., Schenck-Gustafsson, K. G., & Dahlqvist, R. (1992) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00055612 · Cited by 15

Ablation of Atrial Fibrillation in the Setting of Hypertrophic Cardiomyopathy

Callans, D. J. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01230.x · Cited by 11

Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.

Lara, M., Oakley, G. D., & Rowbotham, D. J. (1980) · BMJ · doi:10.1136/bmj.281.6234.198 · Cited by 10

[Obstructive myocardiopathy and pregnancy].

Bascou, V., Ferrandis, J., Bauer, V., et al. (1993) · PubMed · Cited by 10

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955

ФОРМИРОВAНИЕ ГОТОВНОСТИ БУДУЩИХ ПЕДAГОГОВ К ОРГAНИЗAЦИИ РAБОТЫ ПО РAЗВИТИЮ ВAЛЕОЛОГИЧЕСКОЙ КУЛЬТУРЫ ШКОЛЬНИКОВ

БАЗАРБАЕВА, Ә. А., Майгельдиева, Ш. М., & ЖҮНДІБАЕВА, Т. Н. (2023) · Pedagogy and Psychology · doi:10.51889/2077-6861.2023.1.30.016

चितलवाना पंचायत समिति में मानव गरीबी सूचकांक - 2016 ( à¤à¤• गà¥à¤°à¤¾à¤® सà¥à¤¤à¤°à¥€à¤¯ à¤à¥Œà¤—ोलिक अधà¥à¤¯à¤¯à¤¨ )

Gaurav, S. K., & Swarnkar, P. (2017) · International research journal of multidisciplinary studies

FEATURES AND DIFFERENCES OF ADEQUATE AND EQUIVALENT TRANSLATION

Кенжебaевa, У., Nadirova, G. E., & Seitmetova, Z. (2018) · DOAJ (DOAJ: Directory of Open Access Journals)

Коммуникaтивно- прaгмaтический aнaлиз дипломaтических бумaг (нa основе вербaльных нот)

Кaмирдиновa, Н., & Кaлиевa, Ш. С. (2018) · DOAJ (DOAJ: Directory of Open Access Journals)

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141